Candidiasis, Oral Clinical Trial
Official title:
Relationship Between Oral Hygiene in Newborns and Candida Spp.: A Randomized Clinical Trial
Little is known regarding the effectiveness of neonatal oral hygiene and its relationship to colonization by Candida spp. in edentulous oral cavities. Thus, the objective of this study is to evaluate whether the oral hygiene of edentulous infants favors colonization by Candida spp. Newborns with up to 48 hours of life will randomly allocated to two groups. The mothers will instructed to clean the oral cavity with gauze and mineral water three times a day, in the test group, and not to clean, in the control group.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03250923 -
CelAgace™ OraRinse Solution for Treatment of Candidiasis
|
Phase 1/Phase 2 | |
| Completed |
NCT00004781 -
Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups
|
N/A | |
| Completed |
NCT03894839 -
Evaluation of the Effect of Different Cleaning and Disinfection Procedures on the Involvement of Candida Species
|
N/A | |
| Completed |
NCT00128323 -
A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis
|
Phase 3 | |
| Recruiting |
NCT04410250 -
Effect of Oral Hygienization in Newborn on Candida Spp Colonization
|
N/A | |
| Completed |
NCT02184351 -
Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis
|
Phase 3 | |
| Completed |
NCT00665639 -
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis
|
Phase 3 | |
| Completed |
NCT02818803 -
Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic
|
Phase 3 | |
| Recruiting |
NCT06120816 -
Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis
|
Phase 1 | |
| Completed |
NCT00235053 -
Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID
|
Phase 4 | |
| Completed |
NCT00666185 -
Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis
|
Phase 3 | |
| Completed |
NCT00002446 -
Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients
|
Phase 3 | |
| Completed |
NCT00001448 -
The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection
|
N/A | |
| Completed |
NCT00612963 -
Novel Rinse to Treat in Oral Candidiasis in Cancer Patients
|
N/A | |
| Completed |
NCT00001812 -
A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2
|
Phase 3 | |
| Terminated |
NCT00005920 -
Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole
|
Phase 2 | |
| Completed |
NCT00001065 -
A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole
|
Phase 2 | |
| Completed |
NCT00000951 -
A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush
|
Phase 4 | |
| Completed |
NCT00002341 -
A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole
|
N/A | |
| Completed |
NCT00002399 -
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
|
Phase 2 |